MedTrace Logo

UFT/LV Maintenance Vs Observation in Metastatic Breast Cancer Responsive to Chemotherapy

NCT00189631 · Status: UNKNOWN · Phase: PHASE3 · Type: INTERVENTIONAL

Last updated 2005-12-08

No results posted yet for this study

Summary

To compare maintenance therapy to observation in metastatic breast cancer patients responding (or stabilized) after 1st-line chemotherapy. Main endpoint is disease-free survival. Secondary endpoints are overall survival and tolerance. A total of 200 patients will be included.

Conditions

Interventions

PROCEDURE

UFT/LV

PROCEDURE

Observation

Sponsors & Collaborators

  • Bristol-Myers Squibb

    collaborator INDUSTRY

  • Association Européenne de Recherche en Oncologie

    lead OTHER

Principal Investigators

  • Laurent Zelek, MD · AERO

  • Bruno Audhuy, MD · AERO

  • Jean-Francois Berdah, MD · AERO

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Countries

  • France

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00189631 on ClinicalTrials.gov